GE Healthcare’s AIR Recon DL OK’ed for Motion-Insensitive Imaging

GE Healthcare has earned U.S. Food and Drug Administration (FDA) 510(k) clearance for its AIR Recon DL for 3D and PROPELLER imaging sequences.
 
Thanks to the solution’s expanded compatibility from 2D to 3D imaging sequences, diagnosis can be made with improved signal-to-noise ratio (SNR) and sharpness.
 
PROPELLER motion-sensitive imaging sequence is important for anatomies susceptible to motion like respiration during MRI exams, as well as pediatric, neurodegenerative, geriatric, and claustrophobic patients who have difficulty remaining physically still for the duration of an MRI scan.
 
As of September 2022, at least 3.5 million patients globally have been scanned with AIR Recon DL.
 
“By expanding AIR Recon DL to 3D and PROPELLER, GE Healthcare has closed the gaps in our ability to provide improved image quality and patient experience to all our patients across exam types, particularly for brain imaging where we rely heavily on 3D sequences and musculoskeletal imaging where PROPELLER is important for reducing image quality variability and eliminating repeat sequences due to motion,” Dr. Tiron Pechet, Radiologist and Assistant Medical Director at Shields Health Care Group, told the press.
 
AIR Recon DL and the recent extensions are available on new GE Healthcare MRI scanners, and as an upgrade for the vast majority of GE Healthcare’s installed 1.5T and 3.0T MRI systems.